The Most Comprehensive At-Home Gut Microbiome Test Available

GutID's Complete Microbiome Assessment (CMA) is a comprehensive gut microbiome test that goes beyond standard gut health testing. Using patented Titan-1™ long-read sequencing technology, the CMA analyzes your stool sample at the strain level — identifying every bacterium in your gut with unmatched precision — and maps how your microbiome connects to your overall health through four critical gut axes.

Everything in the Core Gut Insights test, plus full gut axis analysis:
The CMA includes all the advanced gut health testing from our CGI kit — microbiome diversity, richness, evenness and resilience scoring, antibiotic resistome profiling, pathogen and beneficial bacteria identification, inflammation risk markers, and gut barrier and mucosa function assessment — plus in-depth analysis across four key biological pathways:

Gut-Brain Axis — Insights related to mood disorders, cognitive health, and Alzheimer's and Parkinson's disease risk
Gut-Metabolism Axis — Insights related to obesity, type 2 diabetes, and non-alcoholic fatty liver disease
Gut-Heart Axis — Insights related to hypertension and atherosclerosis risk
Gut-Immune Axis — Insights related to immune function and eczema (atopic dermatitis)

The CMA also evaluates nutrient and dietary component metabolism, IBS, SIBO, and IBD indicators — giving you or your clinician the most complete picture of your gut health and its impact on your body.

Personalized Recommendations Tailored to Your Unique Microbiome

Your results include customized food recommendations based on your specific bacterial profile, along with personalized supplement, prebiotic, and probiotic suggestions — all designed to help you take targeted action based on what your microbiome actually needs.

Simple At-Home Collection. Lab-Grade Results.

Your easy-to-use test kit includes everything you need for at-home stool sample collection with step-by-step instructions. Ship your sample to our CLIA-certified, CAP-accredited laboratory using the prepaid return envelope. Results are powered by Intus Biosciences' patented Titan-1™ sequencing and AI/ML analysis platform.